Abound Wealth Management
- SEC CIK
- 0001950323
- Latest filing
- Jul 10, 2026
ALNY holding history
Alnylam Pharmaceuticals, Inc. in every 13F filed by Abound Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings
- Shares (Q2 2026)
- 4
- Value
- $1.09K
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 4 | $1.09K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 4 | $1.44K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 4 | $1.73K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 4 | $1.65K | <0.1% | +1+33.3% | Added | Holders |
| Q2 2025 | 3 | $979 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 3 | $811 | <0.1% | −1−25.0% | Reduced | Holders |
| Q4 2024 | 4 | $885 | <0.1% | +1+33.3% | Added | Holders |
| Q3 2024 | 3 | $826 | <0.1% | +3 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −3−100.0% | Sold out | Holders |
| Q1 2024 | 3 | $449 | <0.1% | −1−25.0% | Reduced | Holders |
| Q4 2023 | 4 | $706 | <0.1% | +1+33.3% | Added | Holders |
| Q3 2023 | 3 | $532 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 3 | $570 | <0.1% | +3 | New | Holders |